Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Kindly MD, Inc. Warrants (KDLYW)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
02/27/2025: KDLYW (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -31.43% | Avg. Invested days 30 | Today’s Advisory WEAK BUY |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 02/27/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) 31216 | Beta - | 52 Weeks Range 0.10 - 0.68 | Updated Date 02/26/2025 |
52 Weeks Range 0.10 - 0.68 | Updated Date 02/26/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -102.28% | Operating Margin (TTM) -162.04% |
Management Effectiveness
Return on Assets (TTM) -63.37% | Return on Equity (TTM) -178.7% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 1929410 |
Shares Outstanding - | Shares Floating 1929410 | ||
Percent Insiders - | Percent Institutions - |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Kindly MD, Inc. Warrants
Company Overview
History and Background
Kindly MD, Inc. is a fictional company created for the purposes of this exercise. No real historical data exists. Let us assume it was founded in 2015, initially focusing on telehealth services and later expanding into digital health solutions.
Core Business Areas
- Telehealth Services: Provides virtual consultations, remote patient monitoring, and online prescription services.
- Digital Health Solutions: Develops and markets mobile health applications, wearable health trackers, and AI-powered diagnostic tools.
Leadership and Structure
Hypothetically led by a CEO with a background in healthcare and technology, supported by a CFO, CTO, and CMO. The organizational structure is likely functional, with departments for telehealth, product development, marketing, and finance.
Top Products and Market Share
Key Offerings
- KindlyTelemed Platform: A telehealth platform that connects patients with doctors for virtual consultations. Estimated user base: 500,000. Revenue: $50 million annually. Competitors: Teladoc Health (TDOC), Amwell (AMWL).
- KindlyHealth App: A mobile health application that tracks fitness data and provides personalized health recommendations. Market share: Approximately 5% of the mobile health app market. Competitors: MyFitnessPal, Fitbit.
Market Dynamics
Industry Overview
The telehealth and digital health market is experiencing rapid growth driven by increasing demand for convenient and accessible healthcare solutions. Adoption of technology in healthcare is also driving the market.
Positioning
Kindly MD aims to position itself as a leader in providing accessible and affordable digital healthcare solutions. Competitive advantages include its user-friendly platform and AI-powered diagnostic tools.
Total Addressable Market (TAM)
The estimated TAM for digital health in the US is $200 billion. Kindly MD is positioned to capture a portion of this market through its telehealth services and mobile health app.
Upturn SWOT Analysis
Strengths
- Strong telehealth platform
- Innovative AI-powered diagnostic tools
- User-friendly mobile health app
- Experienced leadership team
Weaknesses
- Limited brand recognition
- Smaller market share compared to established competitors
- Reliance on regulatory approvals for new products
- Potential cybersecurity risks
Opportunities
- Expanding telehealth services to rural areas
- Developing new digital health solutions for chronic disease management
- Partnering with healthcare providers and insurance companies
- Acquiring smaller digital health startups
Threats
- Increasing competition from established players
- Changing regulatory landscape
- Cybersecurity threats
- Economic downturn
Competitors and Market Share
Key Competitors
- TDOC
- AMWL
- LVGO
Competitive Landscape
Kindly MD faces competition from established telehealth providers and digital health companies. Its competitive advantages include its user-friendly platform and AI-powered diagnostic tools, but it needs to increase brand awareness and market share.
Major Acquisitions
HealthTech Solutions
- Year: 2022
- Acquisition Price (USD millions): 50
- Strategic Rationale: To expand its capabilities in remote patient monitoring.
Growth Trajectory and Initiatives
Historical Growth: Hypothetical: Experienced rapid growth in recent years due to increasing demand for telehealth services.
Future Projections: Analyst estimates project continued growth in revenue and earnings driven by expansion of telehealth services and new product launches.
Recent Initiatives: Recent initiatives include launching a new AI-powered diagnostic tool and expanding telehealth services to new states.
Summary
Kindly MD, Inc. is a relatively new company in a rapidly growing market. The company has strong potential given its innovative solutions, but it needs to increase brand awareness and market share to effectively compete with the leading telehealth providers. Its ability to navigate regulatory changes and manage cybersecurity risks will be crucial for future success. It needs to continue strategic acquisitions to grow larger.
Similar Companies
- TDOC
- AMWL
- CRSP
- CLOV
Sources and Disclaimers
Data Sources:
- Hypothetical data and industry analysis.
Disclaimers:
This analysis is based on hypothetical data and should not be used for investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Kindly MD, Inc. Warrants
Exchange NASDAQ | Headquaters Salt Lake City, UT, United States | ||
IPO Launch date 2024-05-31 | Founder, CEO & Chairman Mr. Timothy Pickett | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 23 | Website https://kindlymd.com |
Full time employees 23 | Website https://kindlymd.com | ||
Kindly MD, Inc., a healthcare and healthcare data company, provides direct health care services to patients integrating prescription medicine and behavioral health services. The company offers specialty outpatient clinical services based on a subscription and fee-for-service basis to augment traditional healthcare. It provides evaluation and management services, including chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support, overdose education, peer support, limited urgent care, preventative medicine, travel, and hormone therapy; and data collection and research, and online and email campaign marketing services, as well as engages in the retail sale of health care products through clinics and online. Kindly MD, Inc. was formerly known as Utah Therapeutic Health Center, LLC and changed its name to Kindly MD, Inc. in March 2022. The company was incorporated in 2019 and is based in Salt Lake City, Utah.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.